{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:55:02Z","timestamp":1790934902290,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Ioannina","id":[{"id":"https:\/\/ror.org\/01qg3j183","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06276-0","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:09:16Z","timestamp":1787641756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary amyloidosis, gastric MALT lymphoma, and multiple sclerosis in a patient with Sj\u00f6gren\u2019s disease: a case report and review of the literature"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9528-0583","authenticated-orcid":false,"given":"Nikolaos","family":"Zintziovas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8861-5727","authenticated-orcid":false,"given":"Georgios A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6325-8649","authenticated-orcid":false,"given":"Melina","family":"Yerolatsite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-6177","authenticated-orcid":false,"given":"Anna","family":"Goussia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1314-4535","authenticated-orcid":false,"given":"Vasiliki","family":"Kostadima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8134-9128","authenticated-orcid":false,"given":"Anastasia K.","family":"Zikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"6276_CR1","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.3390\/jcm9123794","volume":"9","author":"IE Stergiou","year":"2020","unstructured":"Stergiou IE, Poulaki A, Voulgarelis M (2020) Pathogenetic mechanisms implicated in Sj\u00f6gren\u2019s syndrome lymphomagenesis: a review of the literature. J Clin Med 9:3794. https:\/\/doi.org\/10.3390\/jcm9123794","journal-title":"J Clin Med"},{"key":"6276_CR2","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2665-9913(24)00183-8","volume":"6","author":"AV Goules","year":"2024","unstructured":"Goules AV, Chatzis LG, Pezoulas VC, Patsouras M, Mavragani CP, Quartuccio L et al (2024) Identification and evolution of predictors of Sj\u00f6gren\u2019s disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study. Lancet Rheumatol 6:e693\u2013e702. https:\/\/doi.org\/10.1016\/S2665-9913(24)00183-8","journal-title":"Lancet Rheumatol"},{"key":"6276_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","volume":"43","author":"JG Routsias","year":"2013","unstructured":"Routsias JG, Goules JD, Charalampakis G, Tzima S, Papageorgiou A, Voulgarelis M (2013) Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 43:178\u2013186. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.04.004","journal-title":"Semin Arthritis Rheum"},{"key":"6276_CR4","doi-asserted-by":"publisher","first-page":"7475242","DOI":"10.1155\/2018\/7475242","volume":"2018","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Sadamatsu H, Ogusu S, Komiya K, Nakamura T, Kimura S et al (2018) Sj\u00f6gren syndrome complicated with cystic lung disease and pulmonary amyloidosis. Case Rep Rheumatol 2018:7475242. https:\/\/doi.org\/10.1155\/2018\/7475242","journal-title":"Case Rep Rheumatol"},{"key":"6276_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.14740\/jmc4336","volume":"15","author":"RL Shakour","year":"2024","unstructured":"Shakour RL, Tascione O, Carberry N, Flores-Gonzalez R (2024) Exploring overlap syndromes: an atypical case of multiple sclerosis with anti-Sjogren\u2019s syndrome type B antibody. J Med Cases 15:387\u2013395. https:\/\/doi.org\/10.14740\/jmc4336","journal-title":"J Med Cases"},{"key":"6276_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.rmcr.2018.11.015","volume":"26","author":"S Heraganahally","year":"2019","unstructured":"Heraganahally S, Digges M, Haygarth M, Liyanaarachchi K, Kalro A, Mehra S (2019) Pulmonary AL amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren\u2019s syndrome. Respir Med Case Rep 26:94\u201397. https:\/\/doi.org\/10.1016\/j.rmcr.2018.11.015","journal-title":"Respir Med Case Rep"},{"key":"6276_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2169\/internalmedicine.8169-21","volume":"61","author":"Y Kinoshita","year":"2022","unstructured":"Kinoshita Y, Ikeda T, Miyamura T, Ueda Y, Yoshida Y, Ueda M et al (2022) Nodular pulmonary amyloidosis associated with Sj\u00f6gren\u2019s syndrome. Intern Med 61:877\u2013881. https:\/\/doi.org\/10.2169\/internalmedicine.8169-21","journal-title":"Intern Med"},{"key":"6276_CR8","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1111\/1756-185X.14753","volume":"26","author":"F Tastekin","year":"2023","unstructured":"Tastekin F, Kerim D, Sen S, Kabasakal Y (2023) Coexistence of Sj\u00f6gren\u2019s syndrome and pulmonary nodular amyloidosis. Int J Rheum Dis 26:2563\u20132566. https:\/\/doi.org\/10.1111\/1756-185X.14753","journal-title":"Int J Rheum Dis"},{"key":"6276_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80092","volume":"17","author":"S Fahad","year":"2025","unstructured":"Fahad S, Khan A, Thapa P, Khan MS, Jogiyat S, Moustafa W et al (2025) Spectrum of neurological complications in Sj\u00f6gren\u2019s syndrome: a comprehensive review. Cureus 17:e80092. https:\/\/doi.org\/10.7759\/cureus.80092","journal-title":"Cureus"},{"key":"6276_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13010014","volume":"13","author":"LV M\u00f3dis","year":"2022","unstructured":"M\u00f3dis LV, Aradi Z, Horv\u00e1th IF, Bencze J, Papp T, Emri M et al (2022) Central nervous system involvement in primary Sj\u00f6gren\u2019s syndrome: narrative review of MRI findings. Diagnostics (Basel) 13:14. https:\/\/doi.org\/10.3390\/diagnostics13010014","journal-title":"Diagnostics (Basel)"},{"key":"6276_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jcm12113672","volume":"27","author":"G Fan","year":"2021","unstructured":"Fan G, Dai F, Chen S, Sun Y, Qian H, Yang G et al (2021) Neurological involvement in patients with primary Sj\u00f6gren\u2019s syndrome. J Clin Rheumatol 27:50\u201355. https:\/\/doi.org\/10.3390\/jcm12113672","journal-title":"J Clin Rheumatol"},{"key":"6276_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/645967","volume":"2012","author":"GJ Tob\u00f3n","year":"2012","unstructured":"Tob\u00f3n GJ, Pers JO, Devauchelle-Pensec V, Youinou P (2012) Neurological disorders in primary Sj\u00f6gren\u2019s syndrome. Autoimmune Dis 2012:645967. https:\/\/doi.org\/10.1155\/2012\/645967","journal-title":"Autoimmune Dis"},{"key":"6276_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-022-06448-w","volume":"42","author":"W Fan","year":"2023","unstructured":"Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L et al (2023) Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 42:443\u2013451. https:\/\/doi.org\/10.1007\/s10067-022-06448-w","journal-title":"Clin Rheumatol"},{"key":"6276_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore) 103:e37297. https:\/\/doi.org\/10.1097\/MD.0000000000037297","journal-title":"Medicine (Baltimore)"},{"key":"6276_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.autrev.2016.01.013","volume":"15","author":"G Masi","year":"2016","unstructured":"Masi G, Annunziata P (2016) Sj\u00f6gren\u2019s syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev 15:457\u2013461. https:\/\/doi.org\/10.1016\/j.autrev.2016.01.013","journal-title":"Autoimmun Rev"},{"key":"6276_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-024-00351-2","volume":"6","author":"KF Jendretzky","year":"2024","unstructured":"Jendretzky KF, Lezius LM, Thiele T, Konen FF, Huss A, Heitmann L et al (2024) Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients. Neurol Res Pract 6:55. https:\/\/doi.org\/10.1186\/s42466-024-00351-2","journal-title":"Neurol Res Pract"},{"key":"6276_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1128315","volume":"14","author":"AM Afzali","year":"2023","unstructured":"Afzali AM, Moog P, Kalluri SR, Hofauer B, Knopf A, Kirschke JS et al (2023) CNS demyelinating events in primary Sj\u00f6gren\u2019s syndrome: a single-center case series on the clinical phenotype. Front Neurol 14:1128315. https:\/\/doi.org\/10.3389\/fneur.2023.1128315","journal-title":"Front Neurol"},{"key":"6276_CR18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Amato MP et al (2025) Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol 24:850\u2013865. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4","journal-title":"Lancet Neurol"},{"key":"6276_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1600-0404.2005.00455.x","volume":"112","author":"L De Santi","year":"2005","unstructured":"De Santi L, Costantini MC, Annunziata P (2005) Long time interval between multiple sclerosis onset and occurrence of primary Sj\u00f6gren\u2019s syndrome in a woman treated with interferon-beta. Acta Neurol Scand 112:194\u2013196. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00455.x","journal-title":"Acta Neurol Scand"},{"key":"6276_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5606\/tftrd.2022.6369","volume":"68","author":"\u015e G\u00fczel","year":"2022","unstructured":"G\u00fczel \u015e, \u00d6zen S (2022) An uncommon case of primary biliary cirrhosis and Hashimoto thyroiditis followed by the concurrent onset of multiple sclerosis and Sj\u00f6gren syndrome. Turk J Phys Med Rehabil 68:154\u2013156. https:\/\/doi.org\/10.5606\/tftrd.2022.6369","journal-title":"Turk J Phys Med Rehabil"},{"key":"6276_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ana.410250117","volume":"25","author":"JH Noseworthy","year":"1989","unstructured":"Noseworthy JH, Bass BH, Vandervoort MK, Ebers GC, Rice GPA, Weinshenker BG et al (1989) The prevalence of primary Sj\u00f6gren\u2019s syndrome in a multiple sclerosis population. Ann Neurol 25:95\u201398. https:\/\/doi.org\/10.1002\/ana.410250117","journal-title":"Ann Neurol"},{"key":"6276_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.42.4.845","volume":"42","author":"M Sandberg-Wollheim","year":"1992","unstructured":"Sandberg-Wollheim M, Ax\u00e9ll T, Hansen BU, Henricsson V, Ingesson E, Jacobsson L et al (1992) Primary Sj\u00f6gren\u2019s syndrome in patients with multiple sclerosis. Neurology 42:845. https:\/\/doi.org\/10.1212\/WNL.42.4.845","journal-title":"Neurology"},{"key":"6276_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ana.410270522","volume":"27","author":"J Mir\u00f3","year":"1990","unstructured":"Mir\u00f3 J, Pe\u00f1a-Sagredo JL, Berciano J, Ins\u00faa S, Leno C, Velarde R (1990) Prevalence of primary Sj\u00f6gren\u2019s syndrome in patients with multiple sclerosis. Ann Neurol 27:582\u2013584. https:\/\/doi.org\/10.1002\/ana.410270522","journal-title":"Ann Neurol"},{"key":"6276_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1212\/wln.57.8.1359","volume":"57","author":"J de Seze","year":"2001","unstructured":"de Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T et al (2001) The prevalence of Sj\u00f6gren syndrome in patients with primary progressive multiple sclerosis. Neurology 57:1359\u20131363. https:\/\/doi.org\/10.1212\/wln.57.8.1359","journal-title":"Neurology"},{"key":"6276_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1600-0404.2010.01428.x","volume":"124","author":"P Annunziata","year":"2011","unstructured":"Annunziata P, De Santi L, Di Rezze S, Millefiorini E, Capello E, Mancardi G et al (2011) Clinical features of Sj\u00f6gren\u2019s syndrome in patients with multiple sclerosis. Acta Neurol Scand 124:109\u2013114. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01428.x","journal-title":"Acta Neurol Scand"},{"key":"6276_CR26","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/art.42550","volume":"75","author":"PM Duret","year":"2023","unstructured":"Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A et al (2023) Association between Bruton\u2019s tyrosine kinase gene overexpression and risk of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 75:1798\u20131811. https:\/\/doi.org\/10.1002\/art.42550","journal-title":"Arthritis Rheumatol"},{"key":"6276_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H et al (2017) CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 89:218\u2013235. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"key":"6276_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"6276_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"6276_CR30","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e225","volume":"39","author":"IC Benlidayi","year":"2024","unstructured":"Benlidayi IC, Gupta L (2024) CAse-BAsed REview sTandards (CABARET): considerations for authors, reviewers, and editors. J Korean Med Sci 39:e225. https:\/\/doi.org\/10.3346\/jkms.2024.39.e225","journal-title":"J Korean Med Sci"},{"key":"6276_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5505\/respircase.2025.48751","volume":"14","author":"KT Karabacak","year":"2025","unstructured":"Karabacak KT, Hoca NT, Demirci NY, Jeyranova G, Demirci AN, Celik A et al (2025) Multiple pulmonary nodules in a patient with Sj\u00f6gren\u2019s syndrome: extranodal marginal zone lymphoma and amyloidosis: a case report. Respir Case Rep 14:47\u201350. https:\/\/doi.org\/10.5505\/respircase.2025.48751","journal-title":"Respir Case Rep"},{"key":"6276_CR32","doi-asserted-by":"crossref","unstructured":"Kisimoto W, Aoyama A, Nakakuki T, Hisizawa M, Miyata H, Omune K, et al. (2026) A case of a maintenance dialysis patient with combined pulmonary-limited AL amyloidosis and MALT lymphoma revealed at autopsy. Kidney Int Rep 11(Suppl):52. Presented at World Congress of Nephrology (WCN\u201926), Yokohama, Japan. Abstract No. 105243","DOI":"10.1016\/j.ekir.2026.105243"},{"key":"6276_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/pgmj.65.763.323","volume":"65","author":"AWG Savage","year":"1989","unstructured":"Savage AWG, Shareef DS, Maher EJ, Bennett MH, Thomas DJB (1989) Lymphoplasmacytoid lymphoma elaborating lambda chain paraprotein with amyloid deposition in Sj\u00f6gren\u2019s syndrome. Postgrad Med J 65:323\u2013326. https:\/\/doi.org\/10.1136\/pgmj.65.763.323","journal-title":"Postgrad Med J"},{"key":"6276_CR34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34286","volume":"15","author":"H Dalal","year":"2023","unstructured":"Dalal H, Yu A, Antoine-Pepeljugoski C (2023) A rare case of breast mucosa-associated lymphoid tissue (MALT) lymphoma with amyloid deposition in a patient with Sj\u00f6gren\u2019s syndrome. Cureus 15:e34286. https:\/\/doi.org\/10.7759\/cureus.34286","journal-title":"Cureus"},{"key":"6276_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2026.102457","volume":"63","author":"Y Murakami","year":"2026","unstructured":"Murakami Y, Goshima M, Tanimoto M, Kobayashi N, Sumida A, Kondo R et al (2026) Pulmonary coexistence of immunoglobulin light chain amyloidosis and light chain deposition disease: a case report. Respir Med Case Rep 63:102457. https:\/\/doi.org\/10.1016\/j.rmcr.2026.102457","journal-title":"Respir Med Case Rep"},{"key":"6276_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2169\/internalmedicine.41.309","volume":"41","author":"N Nakamura","year":"2002","unstructured":"Nakamura N, Yamada G, Itoh T, Suzuki A, Morita-Ichimura S, Teramoto S et al (2002) Pulmonary MALT lymphoma with amyloid production in a patient with primary Sj\u00f6gren\u2019s syndrome. Intern Med 41:309\u2013311. https:\/\/doi.org\/10.2169\/internalmedicine.41.309","journal-title":"Intern Med"},{"key":"6276_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0714.1998.tb02036.x","volume":"27","author":"EW Odell","year":"1998","unstructured":"Odell EW, Lombardi T, Shirlaw PJ, White CAM (1998) Minor salivary gland hyalinisation and amyloidosis in low-grade lymphoma of MALT. J Oral Pathol Med 27:229\u2013232. https:\/\/doi.org\/10.1111\/j.1600-0714.1998.tb02036.x","journal-title":"J Oral Pathol Med"},{"key":"6276_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40792-019-0663-0","volume":"5","author":"S Ohara","year":"2019","unstructured":"Ohara S, Tomizawa K, Shimizu S, Suda K, Fujino T, Hamada A et al (2019) Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis. Surg Case Rep 5:105. https:\/\/doi.org\/10.1186\/s40792-019-0663-0","journal-title":"Surg Case Rep"},{"key":"6276_CR39","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1016\/j.radcr.2024.09.083","volume":"19","author":"Y Watanabe","year":"2024","unstructured":"Watanabe Y, Fujii H, Yamamoto S, Masuoka S, Kobayashi R, Fujii N et al (2024) Parotid gland MALT lymphoma with amyloid deposition: challenges in preoperative diagnosis. Radiol Case Rep 19:6141\u20136146. https:\/\/doi.org\/10.1016\/j.radcr.2024.09.083","journal-title":"Radiol Case Rep"},{"key":"6276_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227581","volume":"12","author":"N Belfeki","year":"2019","unstructured":"Belfeki N, Bellefqih S, Bourgarit A (2019) Breast MALT lymphoma and AL amyloidosis complicating Sj\u00f6gren\u2019s syndrome. BMJ Case Rep 12:e227581. https:\/\/doi.org\/10.1136\/bcr-2018-227581","journal-title":"BMJ Case Rep"},{"key":"6276_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00292-009-1207-3","volume":"30","author":"MJ Flaig","year":"2009","unstructured":"Flaig MJ, Ihrler S (2009) Sj\u00f6gren-assoziiertes MALT-Lymphom der Lippenspeicheldr\u00fcsen: seltene Konstellation mit Amyloidbildung und IgM-Paraprotein\u00e4mie. Pathologe 30:442\u2013445. https:\/\/doi.org\/10.1007\/s00292-009-1207-3","journal-title":"Pathologe"},{"key":"6276_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jcp.56.1.74","volume":"56","author":"M Kambouchner","year":"2003","unstructured":"Kambouchner M, Godmer P, Guillevin L, Rapha\u00ebl M, Droz D, Martin A (2003) Low-grade marginal zone B-cell lymphoma of the breast associated with localised amyloidosis and corpora amylacea in a woman with long-standing primary Sj\u00f6gren\u2019s syndrome. J Clin Pathol 56:74\u201377. https:\/\/doi.org\/10.1136\/jcp.56.1.74","journal-title":"J Clin Pathol"},{"key":"6276_CR43","doi-asserted-by":"publisher","first-page":"A1975","DOI":"10.1016\/j.chest.2020.08.1711","volume":"158","author":"H Li","year":"2020","unstructured":"Li H, Cecchini M, Vassallo R (2020) Coexistence of lymphocytic interstitial pneumonitis, amyloidosis, and MALT lymphoma associated with Sj\u00f6gren\u2019s syndrome. Chest 158:A1975. https:\/\/doi.org\/10.1016\/j.chest.2020.08.1711","journal-title":"Chest"},{"key":"6276_CR44","doi-asserted-by":"publisher","unstructured":"Miyazaki T, Ota S, Mitsukawa S, Sakaida E, Yoshino I (2018) A case of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloidosis. Poster presented at the European Association for Haematopathology (EAHP) Congress, Edinburgh, UK. Poster 80-LYS-P. https:\/\/doi.org\/10.3252\/pso.eu.EAHP2018.2018","DOI":"10.3252\/pso.eu.EAHP2018.2018"},{"key":"6276_CR45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rmed.2013.01.005","volume":"107","author":"M Baqir","year":"2013","unstructured":"Baqir M, Kluka EM, Aubry MC, Hartman TE, Yi ES, Bauer PR et al (2013) Amyloid-associated cystic lung disease in primary Sj\u00f6gren\u2019s syndrome. Respir Med 107:616\u2013621. https:\/\/doi.org\/10.1016\/j.rmed.2013.01.005","journal-title":"Respir Med"},{"key":"6276_CR46","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1016\/S2665-9913(24)00198-X","volume":"6","author":"J Rocca","year":"2024","unstructured":"Rocca J, Beydon M, Le Guern V, Hachulla E, Couderc M, Jousse-Joulin S et al (2024) Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sj\u00f6gren\u2019s disease activity: a multicentre, retrospective, observational study. Lancet Rheumatol 6:e703\u2013e712. https:\/\/doi.org\/10.1016\/S2665-9913(24)00198-X","journal-title":"Lancet Rheumatol"},{"key":"6276_CR47","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/rheumatology\/keac939","volume":"61","author":"LG Chatzis","year":"2022","unstructured":"Chatzis LG, Stergiou IE, Goules AV, Pezoulas V, Tsourouflis G, Fotiadis D et al (2022) Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021). Rheumatology (Oxford) 61:3576\u20133585. https:\/\/doi.org\/10.1093\/rheumatology\/keac939","journal-title":"Rheumatology (Oxford)"},{"key":"6276_CR48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/1744666X.2022.2123794","volume":"18","author":"IE Stergiou","year":"2022","unstructured":"Stergiou IE, Bakasis AD, Giannouli S, Voulgarelis M (2022) Biomarkers of lymphoma in Sj\u00f6gren\u2019s syndrome: what\u2019s the latest? Expert Rev Clin Immunol 18:1155\u20131171. https:\/\/doi.org\/10.1080\/1744666X.2022.2123794","journal-title":"Expert Rev Clin Immunol"},{"key":"6276_CR49","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.55563\/clinexprheumatol\/pjs5h9","volume":"43","author":"LG Chatzis","year":"2025","unstructured":"Chatzis LG, Manfr\u00e8 V, Colangelo A, Delli K, Arends S, Tzioufas AG et al (2025) Clinical manifestations, imaging and treatment of Sj\u00f6gren\u2019s disease: One year in review 2025. Clin Exp Rheumatol 43:2007\u20132019. https:\/\/doi.org\/10.55563\/clinexprheumatol\/pjs5h9","journal-title":"Clin Exp Rheumatol"},{"key":"6276_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.43018","volume":"77","author":"H Achten","year":"2025","unstructured":"Achten H, Meuris L, Deroo L, Jarlborg M, Decruy T, Deprez J et al (2025) Impact of IgG Fc glycosylation on disease dynamics in patients with primary Sj\u00f6gren disease. Arthritis Rheumatol 77:311\u2013321. https:\/\/doi.org\/10.1002\/art.43018","journal-title":"Arthritis Rheumatol"},{"key":"6276_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063259","volume":"25","author":"D Bruno","year":"2024","unstructured":"Bruno D, Tolusso B, Lugli G, Di Mario C, Petricca L, Perniola S et al (2024) B-cell activation biomarkers in salivary glands are related to lymphomagenesis in primary Sj\u00f6gren\u2019s disease: a pilot monocentric exploratory study. Int J Mol Sci 25:3259. https:\/\/doi.org\/10.3390\/ijms25063259","journal-title":"Int J Mol Sci"},{"key":"6276_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00001648-200101000-00023","volume":"12","author":"P Vineis","year":"2001","unstructured":"Vineis P, Crosignani P, Vigan\u00f2 C, Fontana A, Masala G, Stagnaro E et al (2001) Lymphomas and multiple sclerosis in a multicenter case-control study. Epidemiology 12:134\u2013135. https:\/\/doi.org\/10.1097\/00001648-200101000-00023","journal-title":"Epidemiology"},{"key":"6276_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jmg.2007.055012","volume":"45","author":"G Kristjansdottir","year":"2008","unstructured":"Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C et al (2008) Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 45:362\u2013369. https:\/\/doi.org\/10.1136\/jmg.2007.055012","journal-title":"J Med Genet"},{"key":"6276_CR54","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/rheumatology\/key330","volume":"60","author":"J Imgenberg-Kreuz","year":"2021","unstructured":"Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G (2021) Genetics and epigenetics in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 60:2085\u20132098. https:\/\/doi.org\/10.1093\/rheumatology\/key330","journal-title":"Rheumatology (Oxford)"},{"key":"6276_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.857014","volume":"13","author":"X Hong","year":"2022","unstructured":"Hong X, Wang X, Rang X, Yin X, Zhang X, Wang R et al (2022) The shared mechanism and candidate drugs of multiple sclerosis and Sj\u00f6gren\u2019s syndrome analyzed by bioinformatics based on GWAS and transcriptome data. Front Immunol 13:857014. https:\/\/doi.org\/10.3389\/fimmu.2022.857014","journal-title":"Front Immunol"},{"key":"6276_CR56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1586\/1744666X.4.5.573","volume":"4","author":"D Reske","year":"2008","unstructured":"Reske D, Haupt WF (2008) Use of rituximab in multiple sclerosis: current progress and future perspectives. Expert Rev Clin Immunol 4:573\u2013582. https:\/\/doi.org\/10.1586\/1744666X.4.5.573","journal-title":"Expert Rev Clin Immunol"},{"key":"6276_CR57","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, F\u00f6rsti A, Sundquist K, Hemminki K (2014) Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 25:2025\u20132030. https:\/\/doi.org\/10.1093\/annonc\/mdu365","journal-title":"Ann Oncol"},{"key":"6276_CR58","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstr\u00f6m Smedby","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M, Engels EA, Mart\u00ednez-Maza O, Turner J et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029\u20134038. https:\/\/doi.org\/10.1182\/blood-2007-10-119974","journal-title":"Blood"},{"key":"6276_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/aol-20-28","volume":"5","author":"JR Cerhan","year":"2021","unstructured":"Cerhan JR, Habermann TM (2021) Epidemiology of marginal zone lymphoma. Ann Lymphoma 5:1. https:\/\/doi.org\/10.21037\/aol-20-28","journal-title":"Ann Lymphoma"},{"key":"6276_CR60","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/CM9.0000000000000272","volume":"132","author":"KK Yu","year":"2019","unstructured":"Yu KK, Zhu L, Zhao JK, Zhao RY, Han YC (2019) Primary lung mucosa-associated lymphoid tissue lymphoma accompanied by multiple sclerosis. Chin Med J (Engl) 132:1625\u20131628. https:\/\/doi.org\/10.1097\/CM9.0000000000000272","journal-title":"Chin Med J (Engl)"},{"key":"6276_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028969","volume":"8","author":"CC Hemond","year":"2018","unstructured":"Hemond CC, Bakshi R (2018) Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med 8:a028969. https:\/\/doi.org\/10.1101\/cshperspect.a028969","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6276_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020446","volume":"14","author":"E Ishikawa","year":"2022","unstructured":"Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S (2022) Mucosa-associated lymphoid tissue (MALT) lymphoma in the gastrointestinal tract in the modern era. Cancers (Basel) 14:446. https:\/\/doi.org\/10.3390\/cancers14020446","journal-title":"Cancers (Basel)"},{"key":"6276_CR63","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/bloodadvances.2020003889","volume":"5","author":"J Yahalom","year":"2021","unstructured":"Yahalom J, Xu AJ, Noy A, Lobaugh S, Chelius M, Chau K et al (2021) Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients. Blood Adv 5:1830\u20131836. https:\/\/doi.org\/10.1182\/bloodadvances.2020003889","journal-title":"Blood Adv"},{"key":"6276_CR64","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/apt.12635","volume":"39","author":"A Amiot","year":"2014","unstructured":"Amiot A, L\u00e9vy M, Copie-Bergman C, Dupuis J, Szablewski V, Le Baleur Y et al (2014) Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study. Aliment Pharmacol Ther 39:619\u2013628. https:\/\/doi.org\/10.1111\/apt.12635","journal-title":"Aliment Pharmacol Ther"},{"key":"6276_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102578","volume":"95","author":"L Chatzis","year":"2025","unstructured":"Chatzis L, Goules AV, Tzioufas AG (2025) Can we cure Sj\u00f6gren\u2019s disease? Unmet needs and raising questions in the era of precision medicine. Curr Opin Immunol 95:102578. https:\/\/doi.org\/10.1016\/j.coi.2025.102578","journal-title":"Curr Opin Immunol"},{"key":"6276_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00415-020-10362-z","volume":"269","author":"CG Chisari","year":"2022","unstructured":"Chisari CG, Sgarlata E, Arena S, Toscano S, Luca M, Patti F (2022) Rituximab for the treatment of multiple sclerosis: a review. J Neurol 269:159\u2013183. https:\/\/doi.org\/10.1007\/s00415-020-10362-z","journal-title":"J Neurol"},{"key":"6276_CR67","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/art.43207","volume":"77","author":"C Marques","year":"2025","unstructured":"Marques C, R\u00e9gnier P, Maciejewski-Duval A, Richard de Vesvrotte C, Vazquez T, Montardi C et al (2025) Deep immunophenotyping and clustering identifies biomarkers predictive of lymphoma in primary Sj\u00f6gren disease. Arthritis Rheumatol 77:1394\u20131406. https:\/\/doi.org\/10.1002\/art.43207","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06276-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:56Z","timestamp":1790932196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06276-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6276"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06276-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"12 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this manuscript and accompanying clinical data\/images. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board (Protocol code: 73\/28.1.2026).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the participant included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participant provided consent for publication of the study findings.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No artificial intelligence tools were used in the preparation, writing, or analysis of this manuscript.","order":5,"name":"Ethics","label":"Artificial intelligence use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"244"}}